This dual-action mechanism is what distinguishes tirzepatide from semaglutide-based medications like Wegovy, which target GLP-1 receptors only
These findings are particularly exciting because they suggest GLP-1s may have neuroprotective effects that may help improve the quality of life in patients with Parkinsons disease
It would be better to have the placebo group on an existing incretin that is known to be effective, but that probably faces headwinds from both FDA and pharma sponsors
Regulatory Framework: Key FDA Guidance Documents for Nasal Sprays The foundation of nasal spray testing requirements in the United States is established by two primary FDA guidance documents, both from the Center for Drug Evaluation and Research (CDER): FDA CDER 2002 Nasal Spray and Inhalation Solution, Suspension and Spray Drug Products Chemistry, Manufacturing and Controls Documentation (CMC Guidance): Defines the CMC documentation requirements for new drug applications (NDAs) and abbreviated new drug applications (ANDAs) involving nasal spray and inhalation drug products
Let's break it down with some common scenarios for a 20mg vial of Retatrutide
Compare $/mg, not headline vial price - a cheaper vial can cost more per mg